Lung Diseases, Obstructive

• GSK Investigational Site — Erlangen, Bavaria, Germany
• GSK Investigational Site — Kaufbeuren, Bavaria, Germany
• GSK Investigational Site — Landsberg am Lech, Bavaria, Germany
• GSK Investigational Site — Munich, Bavaria, Germany

• Department of Medical Epidemiology and Biostatistics, Karolinska Institutet — Stockholm, Sweden

• Liberty Mutual Research Institute for Safety — Hopkinton, Massachusetts, United States

• Jasper Summit Research, LLC — Jasper, Alabama, United States
• Pulmonary Associates, PA — Phoenix, Arizona, United States
• California Research Medical Group, Inc. — Fullerton, California, United States
• UCLA David Geffen School of Medicine — Los Angeles, California, United States

• UniversityHospitalGrenoble — La Tronche, France

• Children's National Health System — Washington D.C., District of Columbia, United States
• Ann and Robert Lurie Children's Hospital of Chicago — Chicago, Illinois, United States
• Johns Hopkins Children's Center: Department of Allergy & Immunology — Baltimore, Maryland, United States
• Henry Ford Health System: Division of Allergy and Immunology — Detroit, Michigan, United States

• Primary health care center. — Olofström, Blekinge County, Sweden

• Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) — Québec, Quebec, Canada
• Centre de recherche de l'IUCPQ — Québec, Canada

• BUP CPF — Stockholm, Sweden

Not specified